NCT01691677View on ClinicalTrials.gov

beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Acute Rhinosinusitis
Interventions
DRUG

beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days

DRUG

placebo 2 ml suspension for nebulization, one administration b.i.d. for 14 days

Trial Locations (3)

Unknown

Policlinico Santa Maria alle Scotte, Siena

Ospedale Cisanello, Pisa

Policlinico Univesitario Gemelli, Roma

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01691677 - beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study | Biotech Hunter | Biotech Hunter